Critères d'inclusion : - Documented new diagnosis of lung cancer by histology or cytology, or lung tumor leading to lung cancer suspicion without diagnosis for which an antineoplastic treatment is indicated
- Indication of a treatment by surgery, chemotherapy, radio-chemotherapy, radiotherapy or targeted therapy as first line of lung cancer treatment
- ability of the subject to follow study procedures
- Age > 18 years
- Subject must have at least one measurable and/or assessable lesion in regard with RECIST 1.1 criteria
- Subject is registered with a social security scheme
- Subject is taken in charge at Pneumology department of Lille UH
- Subject has signed an informed consent form
Critères de non-inclusion : - Patient with a history of treatment by antineoplastic chemotherapy, radio-chemotherapy, radiotherapy or targeted therapy, or presenting a contra indication to antineoplastic treatment administration
- Subject is not willing to sign the informed consent form
- Subject is not registered with a social security scheme
- Subject is not francophone
- Subject is deprived of his/her liberty or under trusteeship